Cleary Gottlieb Reps DSM In $1B Martek Acquisition

Law360, New York (December 21, 2010, 6:23 PM EST) -- Nutritional and pharmaceutical conglomerate Royal DSM NV said Tuesday it would pay $1.08 billion in cash to acquire microbial nutritional supplement producer Martek Biosciences Corp., in an effort to expand its offerings.

Heerlen, Netherlands-based DSM said it had reached a deal for a tender offer of $31.50 per Martek share, a 35 percent premium over Monday's closing price.

DSM, with annual sales of €8 billion ($10.5 billion) and 22,700 worldwide employees, said the acquisition would expand its presence in the U.S., particularly in the market for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.